Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Exagen (XGN) Long-Term Debt Repayments (2018 - 2025)

Historic Long-Term Debt Repayments for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $162000.0.

  • Exagen's Long-Term Debt Repayments rose 5728.16% to $162000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $532000.0, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $371000.0 for FY2024, which is 9629.0% down from last year.
  • According to the latest figures from Q3 2025, Exagen's Long-Term Debt Repayments is $162000.0, which was up 5728.16% from $158000.0 recorded in Q2 2025.
  • Exagen's 5-year Long-Term Debt Repayments high stood at $9.9 million for Q2 2023, and its period low was -$343000.0 during Q4 2021.
  • For the 5-year period, Exagen's Long-Term Debt Repayments averaged around $773357.1, with its median value being $104000.0 (2024).
  • As far as peak fluctuations go, Exagen's Long-Term Debt Repayments surged by 10845.48% in 2022, and later tumbled by 9901.49% in 2024.
  • Exagen's Long-Term Debt Repayments (Quarter) stood at -$343000.0 in 2021, then soared by 108.45% to $29000.0 in 2022, then surged by 34203.45% to $9.9 million in 2023, then plummeted by 98.94% to $105000.0 in 2024, then skyrocketed by 54.29% to $162000.0 in 2025.
  • Its Long-Term Debt Repayments stands at $162000.0 for Q3 2025, versus $158000.0 for Q2 2025 and $107000.0 for Q1 2025.